Docoh
Loading...
Sign up Log in

SLP Simulations Plus

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. The company's technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide.

Company profile

Ticker
SLP
Exchange
NASDAQ
Website
www.simulations-plus.com
CEO
Shawn M. O'Connor
Employees
Location
California
Fiscal year end
Aug 31
Sector
Professional, Scientific, and Technical Services > Computer Systems Design Services
Industry (SIC)
Services - Computer Integrated Systems Design
Leidos • Godaddy • Unisys • Parsons • Cerner • Allscripts Healthcare Solutions • Caci International Inc. - Registered Shares • Open Text • Jack Henry & Associates • Verint Systems ...
Former names
SIMULATIONS PLUS INC
SEC CIK
0001023459
Corporate docs
IRS number
954595609

SLP stock data

(
)

News

Pro users get this 30m faster
Simulations Plus: Q2 Earnings Insights
12 Apr 21
Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share increased 25.00% over the past year to $0.15, which beat the estimate of $0.14.
Simulations Plus Q2 EPS $0.15 Beats $0.14 Estimate, Sales $13.10M Beat $12.84M Estimate
12 Apr 21
Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.14 by 7.14 percent. This is a 25 percent increase over earnings of $0.12 per share from the
Earnings Scheduled For April 12, 2021
12 Apr 21
Companies Reporting Before The Bell • Aphria (NASDAQ:APHA) is projected to report earnings for its third quarter. • Biofrontera (NASDAQ:BFRA) is projected to report earnings for its fourth quarter.
Simulations Plus's Earnings: A Preview
9 Apr 21
Simulations Plus Reports Successful Results From AIDD Collaboration With 'Large Pharmaceutical Company'
7 Apr 21

Press releases

Pro users get this 30m faster
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
12 Apr 21
Second quarter revenue of $13.1 million, reflecting 27% year-over-year growth Board of Directors announces quarterly dividend of $0.06 per share Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of modeling and
Simulations Plus, Inc. to Host Earnings Call
12 Apr 21
NEW YORK, NY / ACCESSWIRE / April 12, 2021 / Simulations Plus, Inc. (NASDAQ:SLP) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on April 12, 2021 at 4:15 PM Eastern
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
7 Apr 21
80% of preliminary molecules tested exhibit submicromolar activity and acceptable ADME properties Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of modeling and simulation software and services for
Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call
29 Mar 21
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
16 Mar 21

Calendar

11 Jan 21
12 Apr 21
31 Aug 21

Financial summary

Financial statements Chart SLP financial data
Quarter (USD)
 Nov 20 May 20 Feb 20 Nov 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Aug 20 Aug 19 Aug 18 Aug 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Recent insider trades

SLP insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
25 Mar 21 Woltosz Walter S Simulations Plus, Inc. comon stock Sell Aquire S No Yes 60.04 24,000 1.44M 4,527,835
25 Mar 21 Woltosz Walter S Common Stock Sell Dispose S No Yes 61.44 2,506 153.97K 4,527,835
25 Mar 21 Woltosz Walter S Common Stock Sell Dispose S No Yes 60.84 4,856 295.44K 4,530,341
25 Mar 21 Woltosz Walter S Common Stock Sell Dispose S No Yes 59.85 12,529 749.86K 4,535,197
25 Mar 21 Woltosz Walter S Common Stock Sell Dispose S No Yes 58.83 4,109 241.73K 4,547,726
22 Feb 21 Woltosz Walter S Simulations Plus, Inc. common stock Sell Dispose S No Yes 73.01 24,000 1.75M 4,551,835
11 Feb 21 Ralph David L. Common Stock Sell Dispose S No No 84.34 5,000 421.7K 11,802
2 Feb 21 Weiner Daniel L Common Stock Sell Dispose S No No 80.9 5,217 422.06K 2,879
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

SLP institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

63.4% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 190 169 +12.4%
Opened positions 43 34 +26.5%
Closed positions 22 14 +57.1%
Increased positions 60 68 -11.8%
Reduced positions 61 47 +29.8%
13F shares
 Current Prev Q Change
Total value 911.21M 913.91M -0.3%
Total shares 12.66M 12.13M +4.4%
Total puts 28K 13.4K +109.0%
Total calls 30K 62.8K -52.2%
Total put/call ratio 0.9 0.2 +337.4%
Largest owners
 Shares Value Change
BLK Blackrock 2.28M $163.7M +5.5%
ATAC Neuberger Berman 1.2M $86.55M +0.7%
Vanguard 948.45K $68.21M +5.8%
Ranger Investment Management 665.93K $47.89M +50.7%
Dimensional Fund Advisors 487.54K $35.06M -16.2%
STT State Street 485.26K $34.9M -5.3%
IVZ Invesco 449.85K $32.35M +296.7%
Montanaro Asset Management 366.9K $26.39M NEW
Russell Investments 329.13K $23.68M +17.7%
Royce & Associates 321.86K $23.15M +12.9%
Largest transactions
 Shares Bought/sold Change
Montanaro Asset Management 366.9K +366.9K NEW
IVZ Invesco 449.85K +336.45K +296.7%
Lazard Asset Management 0 -318.73K EXIT
Ranger Investment Management 665.93K +223.95K +50.7%
Conestoga Capital Advisors 237.61K +213.11K +869.6%
Jennison Associates 16.06K -170.22K -91.4%
GS Goldman Sachs 57.99K -170.06K -74.6%
Maven Securities 0 -165K EXIT
BLK Blackrock 2.28M +118.97K +5.5%
Hood River Capital Management 0 -99.3K EXIT
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Schrodinger
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: AIDD, APX, authorized, behalf, Certification, compensatory, component, copy, correspondingly, cover, Crest, deducting, deposit, digital, duly, eighteen, eleven, excluded, failure, footage, footnote, foregoing, Frederick, ft, furnish, heart, Inline, instability, Instance, institute, intent, Label, Landlord, Linkbase, LLC, marked, maturity, NC, noncancelable, noncompete, nonlinear, nonmanagement, nonvested, Notwithstanding, NY, omitted, ordinary, page, paper, partially, penalty, purpose, radiation, real, recession, reduction, schedule, Schema, scope, shareholder, Shawn, shelf, spectrum, spending, sq, Ste, Street, syndrome, Taxonomy, thereunto, thousand, threatened, twelve, unasserted, undersigned, underwriting, underwritten, unrealized, upcoming, wage, Wednesday, West, William, XBRL
Removed: absorbed, ACAT, accommodate, accuracy, accurately, achieve, acquiring, actively, acute, add, adding, advance, affecting, agency, aggressively, agreed, AI, AKI, allocating, animal, announced, API, architecture, assisting, attendance, attract, Australia, award, awarded, barrier, bead, behavior, beneficial, big, Bill, bioequivalence, body, borrow, borrowing, build, calculate, capacity, capsule, carrier, cell, Center, chemist, China, choose, chosen, classification, classify, clearance, click, client, code, collaborate, collaboration, collected, commitment, communicate, communication, comparability, compare, compartmental, compete, competitor, compound, conducting, consistent, consortium, constant, consummated, continued, contracted, controlled, coordination, core, count, coupled, create, crystalline, cumulative, cure, customized, CVM, DDI, deal, deep, default, defense, Delaware, delivered, demand, depending, deployment, dermal, dermatological, designing, desired, detailed, di, difficult, directed, Director, disclosing, diseased, disintegration, dissolution, distribute, dominant, dosage, dosed, downloaded, easily, easy, efficacy, efficient, efficiently, elapsed, electronically, elimination, empirical, enable, enabling, end, endpoint, engine, engineering, enhanced, enhancing, enjoy, Enslein, entitled, entry, estimation, Europe, European, evaluate, evenly, examining, exclusive, Excretion, executable, exist, expand, expanding, expended, eye, fat, FDIC, feedback, field, finance, fit, foot, formulation, Foundation, free, fulfill, functionality, funded, funding, GAAP, gastrointestinal, generating, generation, generic, goal, gradually, greater, grow, gut, hand, handled, head, high, hindsight, history, Holding, host, HTPK, human, IA, icon, illustrate, import, improved, inception, incorporate, incorporation, increasingly, independent, individual, inflammation, inform, initially, injectable, injection, installed, instantly, integrate, intelligence, intend, interaction, interconnectivity, interface, intermediate, interplay, interpret, interpretation, intramuscular, investigate, invoiced, invoicing, involved, IPFsym, ISO, Japanese, joined, journal, judgement, kidney, kiwiConnect, KNIME, Korea, larger, layer, leasing, lessee, lessor, leverage, leveraged, library, licensed, licensing, likelihood, long, maintained, MAM, managing, map, mapping, mathematical, MDCK, measuring, Medicine, Melinda, member, microsphere, Modeler, modification, modify, monetize, mutagenicity, nature, NCA, negotiated, nonassertion, nonmem, novo, objective, observation, OCAT, ocular, offered, OGD, online, opening, optional, oral, organize, organized, output, outsource, outsourcing, package, parent, partner, past, penetrate, people, perfusion, permeability, permitted, perpetrator, perpetual, phenomena, physical, Pilot, Pipeline, PK, podium, poor, post, powder, predicted, predictive, presently, previously, primary, printed, production, promised, proven, published, pursue, push, qualify, quality, quickly, RCA, recognizing, regression, regular, relate, reliable, relied, relinquished, rely, remotely, RENAsym, repository, representation, reproducible, Republic, reputation, requested, researcher, retain, retained, retrospective, retrospectively, Rochester, rounding, run, salary, selected, selection, sense, Sensitivity, separately, serve, showed, shrink, significance, simple, simulated, simulator, Singapore, site, size, sketcher, skilled, skin, small, smaller, solubility, South, specific, standalone, statistical, steadily, strategically, streamlined, structural, substance, substantially, successful, successfully, suggested, summer, supporting, supposedly, system, tablet, Taiwan, targeted, TCAT, team, tighter, timing, tissue, tool, top, topical, toxicity, toxicology, traditional, traditionally, transdermal, transfer, Transit, transition, transparency, transporter, TSRL, twenty, Typical, typically, underlying, understand, unfunded, unlocked, updated, usable, user, utilize, validate, validated, valuable, variability, variable, variety, Veterinary, victim, virtual, visualization, vitro, vivo, web, website, widespread, Wizard, workflow, workload, wrap, Zealand
From filing 10-Q 2021 Q1

Financial reports

View all
10-Q
2021 Q1
Quarterly report
11 Jan 21
10-K
2020 FY
Annual report
15 Nov 20
10-Q/A
2020 Q3
Quarterly report (amended)
24 Jul 20
10-Q
2020 Q3
Quarterly report
9 Jul 20
10-Q
2020 Q2
Quarterly report
9 Apr 20
10-Q
2020 Q1
Quarterly report
9 Jan 20
10-K
2019 FY
Annual report
13 Nov 19
10-Q
2019 Q3
Quarterly report
10 Jul 19
10-Q
2019 Q2
Quarterly report
9 Apr 19
10-Q
2019 Q1
Quarterly report
9 Jan 19

Current reports

View all
8-K
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
12 Apr 21
8-K
Departure of Directors or Certain Officers
1 Mar 21
8-K
Regulation FD Disclosure
18 Feb 21
8-K
Regulation FD Disclosure
15 Jan 21
8-K
Simulations Plus Reports Record First Quarter FY2021 Financial Results
11 Jan 21
8-K
Entry into a Material Definitive Agreement
4 Jan 21
8-K
Regulation FD Disclosure
18 Dec 20
8-K
Cost Associated with Exit or Disposal Activities
1 Dec 20
8-K
Simulations Plus Reports FY2020 and Fourth Quarter FY2020 Financial Results
16 Nov 20
8-K
Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
13 Oct 20

Registration and prospectus

View all
424B5
Prospectus supplement for primary offering
6 Aug 20
424B5
Prospectus supplement for primary offering
4 Aug 20
S-3ASR
Automatic shelf registration
9 Jul 20
S-8
Registration of securities for employees
24 Jul 17
S-8
Registration of securities for employees
27 Jul 14
25
Voluntary exchange delisting
26 Dec 07
8-A12B
Registration of securities on exchange
17 Dec 07
S-8
Registration of securities for employees
10 May 07
8-A12B
Registration of securities on exchange
15 Mar 04
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Jul 02

Proxies

View all
DEF 14A
Definitive proxy
29 Dec 20
PRE 14A
Preliminary proxy
17 Dec 20
DEF 14A
Definitive proxy
30 Dec 19
DEF 14A
Definitive proxy
31 Dec 18
PRE 14A
Preliminary proxy
20 Dec 18
DEF 14A
Definitive proxy
28 Dec 17
DEF 14A
Definitive proxy
28 Dec 16
DEF 14A
Definitive proxy
28 Dec 15
DEF 14A
Definitive proxy
28 Dec 14
DEF 14A
Definitive proxy
25 Dec 13

Other

View all
UPLOAD
Letter from SEC
2 Jan 11
CORRESP
Correspondence with SEC
28 Dec 10
CORRESP
Correspondence with SEC
22 Dec 10
UPLOAD
Letter from SEC
21 Dec 10
UPLOAD
Letter from SEC
29 Mar 10
CORRESP
Correspondence with SEC
14 Mar 10
UPLOAD
Letter from SEC
9 Mar 10
CORRESP
Correspondence with SEC
9 Feb 10
UPLOAD
Letter from SEC
28 Jan 10
CORRESP
Correspondence with SEC
13 Jan 10

Ownership

View all
4/A
Simulations Plus / WALTER S WOLTOSZ ownership change
1 Apr 21
4
Simulations Plus / WALTER S WOLTOSZ ownership change
25 Mar 21
4/A
Simulations Plus / WALTER S WOLTOSZ ownership change
23 Feb 21
4
Simulations Plus / David L. Ralph ownership change
12 Feb 21
SC 13G/A
Simulations Plus / Neuberger Berman ownership change
11 Feb 21
4/A
Simulations Plus / WALTER S WOLTOSZ ownership change
10 Feb 21
4
Simulations Plus / DANIEL L WEINER ownership change
4 Feb 21
4
Simulations Plus / DANIEL L WEINER ownership change
3 Feb 21
4
Simulations Plus / David L. Ralph ownership change
3 Feb 21
4
Simulations Plus / John Kenneth Paglia ownership change
3 Feb 21

Patents

GRANT
Utility
Product and method to decrease torsional loads induced in sabots and riders in rifled gun bores
16 Feb 21
Disclosed herein is sabot for a sub-caliber projectile comprising a plurality of petals, such that a slip mechanism can be incorporated between the sabot petals and the pusher mechanism to decrease or prevent the sabot from rotating in a rifled gun bore, or the petals themselves can be separated into forward petals and aft petals, with only the aft petals rotating along with the gun rifle.
GRANT
Utility
Sabot, bore rider, and methods of making and using same
7 Dec 20
Sabots and riders are described herein that have high torsional stiffness, providing for utility in high-speed projectiles.

Transcripts

View all
2021 Q1
Earnings call transcript
12 Jan 21
2020 Q4
Earnings call transcript
16 Nov 20
2020 Q3
Earnings call transcript
9 Jul 20
2020 Q2
Earnings call transcript
10 Apr 20
2020 Q1
Earnings call transcript
9 Jan 20
2019 Q4
Earnings call transcript
13 Nov 19
2019 Q3
Earnings call transcript
10 Jul 19
2019 Q2
Earnings call transcript
9 Apr 19
2019 Q1
Earnings call transcript
9 Jan 19
2018 Q4
Earnings call transcript
14 Nov 18

Reddit threads

View all